A new study funded by the American Foundation for Suicide Prevention is recruiting people currently experiencing symptoms of depression and suicidal thoughts. 

All eligible will receive one infusion of Ketamine followed by 4 weeks of a medication or placebo.

You may be eligible to participate in this 6 week study if you are between 18-70 years of age and have not responded to previous depression treatment.

To learn more about our current research and to complete the online screening form log onto our website
  www.med.stanford.edu/drc